The effect of Trinitroglycerine injection on angiographic complications
Phase 2
- Conditions
- Diseases of the circulatory system.
- Registration Number
- IRCT138901283733N1
- Lead Sponsor
- Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 223
Inclusion Criteria
signing informed consent, age between 20 and 75 years, no drug addiction, lack of brain vascular disease and systolic blood pressure above 100 mmHg, candidates for angiography, hemodynamic stability,
Exclusion criteria: history of heart disease, history of hypertension
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ausea. Timepoint: during angiography. Method of measurement: patient observation and expression.;Coronary artery spasm. Timepoint: during angiography. Method of measurement: angiography film.;Chest pain. Timepoint: during angiography. Method of measurement: Pain by the patient during angiography is reported ECG changes in addition to rising or down piece ST.;Systolic and diastolic blood pressure. Timepoint: during angiography. Method of measurement: monitoring intravascular pressure device that was attached to the patient during angiography.;Brady arrhythmia. Timepoint: during angiography. Method of measurement: ECG monitoring during angiography.
- Secondary Outcome Measures
Name Time Method